ABSTRACT
Menopause is characterized by a reduction in sex hormones in women and is associated with metabolic changes, including fatty liver and insulin resistance. Lifestyle changes, including a balanced diet and physical exercise, are necessary to prevent these undesirable changes. Strength training (ST) has been widely used because of the muscle and metabolic benefits it provides. Our study aims to evaluate the effects of ST on hepatic steatosis and insulin resistance in ovariectomized mice fed a high-fat diet (HFD) divided into four groups as follows: simulated sedentary surgery (SHAM-SED), trained simulated surgery (SHAM-EXE), sedentary ovariectomy (OVX-SED), and trained ovariectomy (OVX-EXE). They were fed an HFD for 9 weeks. ST was performed thrice a week. ST efficiently reduced body weight and fat percentage and increased lean mass in OVX mice. Furthermore, ST reduced the accumulation of ectopic hepatic lipids, increased AMPK phosphorylation, and inhibited the de novo lipogenesis pathway. OVX-EXE mice also showed a better glycemic profile, associated with greater insulin sensitivity identified by the euglycemic-hyperinsulinemic clamp, and reduced markers of hepatic oxidative stress compared with sedentary animals. Our data support the idea that ST can be indicated as a non-pharmacological treatment approach to mitigate metabolic changes resulting from menopause.
Subject(s)
Diet, High-Fat , Fatty Liver , Insulin Resistance , Ovariectomy , Resistance Training , Animals , Female , Ovariectomy/adverse effects , Diet, High-Fat/adverse effects , Mice , Fatty Liver/metabolism , Fatty Liver/prevention & control , Physical Conditioning, Animal , Oxidative Stress , Liver/metabolism , Mice, Inbred C57BL , Body Weight , LipogenesisABSTRACT
Several models of mice-fed high-fat diets have been used to trigger non-alcoholic steatohepatitis and some chemical substances, such as carbon tetrachloride. The present study aimed to evaluate the joint action of a high-fat diet and CCl4 in developing a short-term non-alcoholic steatohepatitis model. C57BL6/J mice were divided into two groups: standard diet-fed (SD), the high-fat diet-fed (HFD) and HFD + fructose-fed and carbon tetrachloride (HFD+CCl4). The animals fed with HFD+CCl4 presented increased lipid deposition compared with both SD and HFD mice. Plasma cholesterol was increased in animals from the HFD+CCl4 group compared with the SD and HFD groups, without significant differences between the SD and HFD groups. Plasma triglycerides showed no significant difference between the groups. The HFD+CCl4 animals had increased collagen deposition in the liver compared with both SD and HFD groups. Hydroxyproline was also increased in the HFD+CCl4 group. Liver enzymes, alanine aminotransferase and aspartate aminotransferase, were increased in the HFD+CCl4 group, compared with SD and HFD groups. Also, CCl4 was able to trigger an inflammatory process in the liver of HFD-fed animals by promoting an increase of â¼2 times in macrophage activity, â¼6 times in F4/80 gene expression, and pro-inflammatory cytokines (IL-1b and TNFa), in addition to an increase in inflammatory pathway protein phosphorylation (IKKbp). HFD e HFD+CCl4 animals increased glucose intolerance compared with SD mice, associated with reduced insulin-stimulated AKT activity in the liver. Therefore, our study has shown that short-term HFD feeding associated with fructose and CCl4 can trigger non-alcoholic steatohepatitis and cause damage to glucose metabolism.
Subject(s)
Carbon Tetrachloride , Diet, High-Fat , Disease Models, Animal , Liver , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease , Animals , Non-alcoholic Fatty Liver Disease/etiology , Non-alcoholic Fatty Liver Disease/metabolism , Non-alcoholic Fatty Liver Disease/pathology , Diet, High-Fat/adverse effects , Liver/metabolism , Liver/pathology , Male , Mice , Triglycerides/blood , Triglycerides/metabolism , Fructose/adverse effectsABSTRACT
Dehydroespiandrosterone (DHEA) is associated with improvements in chronic degenerative diseases, including obesity, insulin resistance, and cardiovascular diseases. Nevertheless, it is observed an increase in its concentration in individuals with liver lipid infiltration, but it is not precise if this condition emerges as a cause or a consequence. In this way, we aimed to identify gene expression alterations in lipid and glucose liver metabolism markers, as well as oxidative stress markers. For this purpose, male Wistar rats, 12-14 months old were treated with subcutaneous injections of DHEA (only dose of 10 mg kg-1); and after 7 days, hepatic gene expression by PCR real time were performed for the following genes: G6Pase, PEPCK, FAS, PPARγ, malic enzyme, ChREBP, LXR, catalase, GPx, iNOS, NADPH oxidase subunits and PCNA. We observed a tendency of reduction in G6Pase gene expression in treated group (p = 0.08). In addition, it was identified an increase in liver PPARγ and FAS gene expressions, two markers of increased activity of lipogenic pathway. We also observed an increase in iNOS gene expression, a known inductor of systemic and hepatic insulin resistance. In conclusion, our data indicates that the treatment with DHEA can be associated with the development of liver lipid infiltration and hepatic insulin resistance.
A deidroepiandrosterona (DHEA) encontra-se associada a melhorias em quadros de obesidade, resistência à insulina e doenças cardiovasculares. Porém, observa-se um aumento na sua concentração em indivíduos portadores de infiltração lipídica hepática, mas sem saber precisar se o mesmo surge como causa ou consequência. Assim, objetivamos identificar alterações na expressão gênica hepática de marcadores relacionados ao metabolismo lipídico e glicídico e de estresse oxidativo. Para tanto, ratos machos com 12-14 meses de idade foram tratados com injeção subcutânea de DHEA (dose única 10 mg kg-1), e após 7 dias foram feitas análises da expressão gênica hepática por PCR em tempo real das seguintes proteínas: G6Pase, PEPCK, FAS, PPARγ, enzima málica, ChREBP, LXR, catalase, GPx, iNOS, subunidades da NADPHoxidase e PCNA. Observamos uma tendência à redução da expressão gênica da G6Pase no grupo tratado (p = 0,08). Também identificamos um aumento na expressão gênica hepática do PPARγ e FAS, dois indicadores de aumento da atividade das vias de lipogênese. Observamos um aumento na expressão gênica da iNOS, um conhecido agente indutor de resistência insulina sistêmica e hepática. Em conclusão, nossos dados indicam que o tratamento com DHEA pode estar associado com o desenvolvimento de um quadro de infiltração lipídica hepática e resistência à insulina hepática.